Key Developments: Nestle SA (NESN.VX)

NESN.VX on Virt-X Level 1

71.90CHF
11:31am EST
Change (% chg)

CHF1.05 (+1.48%)
Prev Close
CHF70.85
Open
CHF71.60
Day's High
CHF71.90
Day's Low
CHF71.15
Volume
7,451,203
Avg. Vol
6,327,119
52-wk High
CHF77.00
52-wk Low
CHF65.70

Search Stocks

Latest Key Developments (Source: Significant Developments)

East African supermarket chain takes Nestle SA's Maggi off shelves - Mint
Tuesday, 9 Jun 2015 08:00pm EDT 

Nestle SA:Says East African supermarket chain Nakumatt has decided to withdraw Nestle's Maggi noodles from its shops across five countries, Kenya, Uganda, Tanzania, Rwanda and South Sudan, according to a BBC report - Mint.Nakumatt has taken Maggi off shelves following a complaint by the Consumer Federation of Kenya (Cofek).Cofek said two more supermarket chains in Kenya, Tuskys and Naivas, have agreed to withdraw Maggi from their stores, BBC reported.  Full Article

Nestle says Wan Ling Martello to step down as CFO
Friday, 17 Apr 2015 12:01pm EDT 

Nestle SA:Wan Ling Martello to step down as CFO and replace Nandu Nandkishore as Executive Vice President in charge of Zone AOA as of May 1.Wan Ling Martello's replacement as CFO will be announced in due course.In the meantime, Paul Bulcke assumes these responsibilities with the assistance of Group Accounting and Reporting Head Stefan Helfenstein.  Full Article

Nestle SA announces exclusive negotiations for sale of Davigel
Wednesday, 15 Apr 2015 02:00am EDT 

Nestle SA:Enters into exclusive negotiations for the sale of Davigel with the Brakes Group, an European food service operator owned by the private equity manager Bain Capital.Transaction is subject to consultations with the relevant works councils and the approval of the competition authorities.Financial details are not being disclosed.  Full Article

Nestle SA to propose increase in dividend
Thursday, 19 Feb 2015 02:03am EST 

Nestle SA:To propose an increase in the dividend to CHF 2.20 per share.Last trading day with entitlement to receive the dividend is April 17.Net dividend will be payable as from April 22.Shareholders who are on record in the share register with voting rights on April 9 will be entitled to exercise their voting rights.  Full Article

L'Oreal and Nestle end joint venture Inneov
Thursday, 27 Nov 2014 12:01pm EST 

L'Oreal SA and Nestle:Announce project to end their joint venture Inneov during course of Q1 2015.Say brand has not met development expected by both partners.Say both partners will keep benefits of research and intellectual property as well as developments achieved which could be potentially used in their respective field.Say to be committed to review all employment opportunities within their Groups for all employees of Inneov.  Full Article

Nestle SA confirms FY 2014 sales outlook
Thursday, 16 Oct 2014 01:15am EDT 

Nestle SA:Says is still aiming for organic sales growth of around 5 pct for FY 2014.  Full Article

Nestle SA confirms FY 2014 outlook; plans to launch 8 billion Swiss francs share buy-back programme
Thursday, 7 Aug 2014 01:15am EDT 

Nestle SA:Says FY 2014 outlook confirmed: organic growth around 5 pct and improvements in margins, underlying earnings per share in constant currencies and capital efficiency.Plans to launch new share buy-back programme of 8 billion Swiss francs that will start this year and continue into 2015.  Full Article

Nestle SA completed acquisition of Valeant Pharmaceuticals's commercialisation rights
Thursday, 10 Jul 2014 09:35am EDT 

Nestle SA:Completed its acquisition of Valeant Pharmaceuticals International's commercialisation rights to several key injectable aesthetic dermatology products in US and Canada, as announced on May 28.These rights will be integrated into NestlĂ© Skin Health and commercialised by Galderma.  Full Article

L'Oreal finalizes disposal of its 50 pct ownership in Galderma to Nestle
Tuesday, 8 Jul 2014 12:00pm EDT 

L'Oreal SA:Finalizes disposal of its 50 pct ownership in Galderma to Nestle.  Full Article

Valeant Pharmaceuticals International Inc to sell Filler And Toxin assets to Nestle
Wednesday, 28 May 2014 01:15am EDT 

Valeant Pharmaceuticals International Inc:Agreement to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 bln in cash.Nestle expects to complete acquisition of Galderma S.A. in July and would expect to operate acquired assets through Galderma.Transaction is subject to customary closing conditions, including clearance or early expiration of waiting period under Hart-Scott-Rodino (HSR) Act and is not contingent upon successful transaction with Allergan, Inc.Transaction is extremely attractive both to Valeant and Galderma, and dovetails well with our announced plans for a transaction with Allergan.  Full Article

Photo

Consumer companies' outperformance no longer guaranteed by cheap oil

LONDON Consumer companies are offering investors a small degree of relief from the turmoil in banking and resources in a results season dominated by fears about slowing economic growth.

Search Stocks